Abdera Therapeutics Inc.
1 clinical trials · Sponsor
◉ Watch Abdera Therapeutics Inc.
| Record | Firm | Date |
|---|---|---|
| Study of 225Ac-ABD147 to Establish Optimal Dose in Patients With SCLC and LCNEC of the Lung That Previously Received Platinum-based Chemotherapy (NCT06736418) | Abdera Therapeutics Inc. | 2025-03-10 |
Track Abdera Therapeutics Inc. automatically
Every clearance here is in the API, with alerts when new ones post.